Genetic Diversity and Chromosomal Variations in the Iranian Leishmania major Strain: Insights into Pathogenicity and

Hanieh Sharifian1, Anis Khalafiyan2, Mahmood Fadaie1,2

  • 1Skin Diseases and Leishmaniasis Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

PubMed
Abstract

Insights

Genetic variations in Leishmania major, including chromosomal changes and single nucleotide polymorphisms (SNPs), influence cutaneous leishmaniasis (CL) clinical differences and treatment resistance. These findings highlight the importance of genetic diversity in disease pathogenesis.

Area of Science:

  • Genomics
  • Parasitology
  • Medical Entomology

Background:

  • Leishmaniasis is a significant global health issue caused by protozoan parasites transmitted by sand flies.
  • Cutaneous leishmaniasis (CL), primarily caused by *Leishmania major*, presents diverse clinical forms in Iran.
  • Understanding the genetic basis of *L. major* is crucial for addressing disease variability and treatment challenges.

Purpose of the Study:

  • To investigate the impact of genetic diversity in *Leishmania major* on clinical manifestations of cutaneous leishmaniasis.
  • To analyze chromosomal count variations, single nucleotide polymorphisms (SNPs), and insertions/deletions (Indels) in an Iranian *L. major* strain.

Main Methods:

  • Whole genome sequencing of the Iranian *Leishmania major* strain MRHO/IR/75/ER using next-generation sequencing.
  • Bioinformatics tools were employed for data alignment, variant calling, and identification of chromosomal variations, SNPs, and Indels.

Main Results:

  • Significant karyotypic variations were observed, including monosomy on chromosome 2 and trisomy on chromosomes 5, 13, 28, and 31.
  • A total of 144,509 genetic variants (SNPs and Indels) were identified, with 99% located in coding regions.
  • Key genes such as *MRPA*, *HSP70.4*, *GP63*, and *CPA* showed substantial alterations, potentially impacting drug resistance and pathogenicity.

Conclusions:

  • This study elucidates the genetic diversity of *L. major* and its correlation with disease progression and treatment outcomes.
  • The identified genetic variations provide insights into the mechanisms underlying drug resistance and pathogenicity.
  • Further functional studies are recommended to validate these findings and their clinical implications.